Eva Hurt-Camejo

Eva Hurt-Camejo

AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 5293102
-
person_outline Eva Hurt-Camejo's MOST POPULAR ARTICLES
1-) Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetesE Leinonen, E Hurt-Camejo, O Wiklund, LM Hultén, A Hiukka, ...Atherosclerosis 166 (2), 387-394, 20034962003
2-) Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basisG Camejo, E Hurt-Camejo, O Wiklund, G BondjersAtherosclerosis 139 (2), 205-222, 19984531998
3-) Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysisR Kleemann, L Verschuren, MJ van Erk, Y Nikolsky, NHP Cnubben, ...Genome biology 8, 1-16, 20072792007
4-) Phospholipase A2 in Vascular DiseaseE Hurt-Camejo, G Camejo, H Peilot, K Öörni, P KovanenCirculation research 89 (4), 298-304, 20012812001
5-) Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.E Hurt-Camejo, G Camejo, B Rosengren, F Lopez, C Ahlström, G Fager, ...Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 12 (5), 569-583, 19922531992